Mefro Pharmaceuticals Pvt Ltd
About Mefro Pharmaceuticals Pvt Ltd
Data last updated:
Mefro Pharmaceuticals Pvt Ltd is a private limited company based in Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 May 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB1995PTC016505. Its GSTIN is 03AADCM5006E1Z5 (Punjab).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rajesh Chopra and Gamini Chopra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at F 68 Phase 7 Industrial Area S A S Nagar Mohali Distt Ropar, Punjab, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.17 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹15.61 Lakh (net margin 7.2%) and EBITDA of ₹15.61 Lakh (EBITDA margin 7.2%).
As per MCA filings, the company has open charges of ₹2.24 Cr and satisfied charges of ₹1.5 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mefro Pharmaceuticals Pvt Ltd's registered office is in Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF 68 Phase 7 Industrial Area S A S Nagar Mohali Distt Ropar, Punjab, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mefro Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mefro Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Mefro Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Mefro Pharmaceuticals Pvt Ltd
FY 2024 filings availableMefro Pharmaceuticals Pvt Ltd reported revenue of ₹2.17 Cr (up 1341% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 7.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mefro Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Mefro Pharmaceuticals Pvt Ltd
Mefro Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Chopra Also directs: Derma Story Limited, Horizon Formulations Private Limited | Director | 23 Oct 2000 | 26 Years 0 Months | Current |
| Gamini Chopra | Director | 15 Feb 2001 | 25 Years 8 Months | Current |
Auditor
Mefro Pharmaceuticals Pvt Ltd is audited by MANDHAR AND ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANDHAR AND ASSOCIATES | FY 2024 | 033209N |
Shareholding
The shareholding of Mefro Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mefro Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jul 2020 | 100349121 | Others | ₹89 Lakh | Open | |
| 01 Sep 2014 | 10522664 | Icici Bank Limited | ₹1 Cr | Open | |
| 15 Feb 2005 | 90175677 | State Bank of India | ₹30 Lakh | Open | |
| 26 Aug 1996 | 90173349 | State Bank of India | ₹4.72 Lakh | Open | |
| 24 Apr 2013 | 10430961 | India Infoline Finance Limited | ₹60 Lakh | Satisfied |
To see the full charge records of Mefro Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 7 View all charges
Legal cases
Mefro Pharmaceuticals Pvt Ltd has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Appeal | Filed against the company by Pfizer Ltd. | Disposed |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by an individual | Disposed |
To see the full case history of Mefro Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mefro Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mefro Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCM5006E1Z5 | Punjab | Active | 18 Dec 2024 |
To see the full GST registrations and return filing status of Mefro Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Mefro Pharmaceuticals Pvt Ltd has 2 board changes on record since 2000: 2 appointments. The latest: Gamini Chopra was appointed as Director on 15 Feb 2001.
3 earlier events are in the company report.
Frequently asked questions
Mefro Pharmaceuticals is an active private limited company based in Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 May 1995 (31+ years old) and is registered under CIN U24232PB1995PTC016505.
Mefro Pharmaceuticals has 2 current directors:
- Rajesh Chopra - Director
- Gamini Chopra - Director
The latest financial statements of Mefro Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Mefro Pharmaceuticals is 03AADCM5006E1Z5, registered in Punjab.
The CIN (Corporate Identification Number) of Mefro Pharmaceuticals is U24232PB1995PTC016505. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mefro Pharmaceuticals has 2 court cases on record: 2 filed against it.
Mefro Pharmaceuticals was incorporated on 29 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Chandigarh.
Gamini Chopra was appointed as Director on 15 Feb 2001. Rajesh Chopra was appointed as Director on 23 Oct 2000.
The registered office of Mefro Pharmaceuticals is at F 68 Phase 7 Industrial Area S A S Nagar Mohali Distt Ropar, Punjab, India.
Mefro Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
